Regulatory challenges surrounding Orphan drug development
Successful development plan for Orphan Drug
Commercial aspects of orphan drug development
Developing patient registries
Patient perspective
Who should Attend
CMO, CEO, Corporate Development and CSO from biotechnology companies
VPs, Presidents, Heads/Managers and Directors of (within sectors – CV, Oncology, AutoImmune and Respiratory): Therapeutic Development, (Orphan) Drug Discovery/Development, Business Unit, Marketing & Medical Affairs, External Affairs, Regulatory Affairs and Market Access From pharmaceutical companies
Academics, Regulatory Bodies and Research centres
Past Events
2nd Annual Orphan Drug Congress 2012 - 07-08 Jun 2012, Barcelona, Spain (25734)
Orphan Drug Congress 2011 - 04-05 May 2011, Vienna, Austria (14675)
Annual Orphan Drug Congress 2026
Important
Please, check "Annual Orphan Drug Congress" official website for possible changes, before making any traveling arrangements
